Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

Abstract

Nonalcoholic fatty liver disease (NAFLD) clusters in families, but the only known common genetic variants influencing risk are near PNPLA3. We sought to identify additional genetic variants influencing NAFLD using genome-wide association (GWA) analysis of computed tomography (CT) measured hepatic steatosis, a non-invasive measure of NAFLD, in large population based samples. Using variance components methods, we show that CT hepatic steatosis is heritable (∼26%-27%) in family-based Amish, Family Heart, and Framingham Heart Studies (n = 880 to 3,070). By carrying out a fixed-effects meta-analysis of genome-wide association (GWA) results between CT hepatic steatosis and ∼2.4 million imputed or genotyped SNPs in 7,176 individuals from the Old Order Amish, Age, Gene/Environment Susceptibility-Reykjavik study (AGES), Family Heart, and Framingham Heart Studies, we identify variants associated at genome-wide significant levels (p<5×10(-8)) in or near PNPLA3, NCAN, and PPP1R3B. We genotype these and 42 other top CT hepatic steatosis-associated SNPs in 592 subjects with biopsy-proven NAFLD from the NASH Clinical Research Network (NASH CRN). In comparisons with 1,405 healthy controls from the Myocardial Genetics Consortium (MIGen), we observe significant associations with histologic NAFLD at variants in or near NCAN, GCKR, LYPLAL1, and PNPLA3, but not PPP1R3B. Variants at these five loci exhibit distinct patterns of association with serum lipids, as well as glycemic and anthropometric traits. We identify common genetic variants influencing CT-assessed steatosis and risk of NAFLD. Hepatic steatosis associated variants are not uniformly associated with NASH/fibrosis or result in abnormalities in serum lipids or glycemic and anthropometric traits, suggesting genetic heterogeneity in the pathways influencing these traits.

Cited by papers we hold 29

• Alcohol-associated liver disease · 2024
  No notice
• Targeted protein degradation: advances in drug discovery and clinical practice · 2024
  No notice
• Multiomics study of nonalcoholic fatty liver disease · 2022
  No notice
• A genome-wide association study of serum proteins reveals shared loci with common diseases · 2022
  No notice
• rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis · 2021
  No notice
• Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease · 2021
  No notice
• Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning · 2021
  No notice
• Kidney and vascular function in adult patients with hereditary fructose intolerance · 2020
  Not checked
• A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus · 2020
  Not checked
• The association of genetic polymorphisms with nonalcoholic fatty liver disease in a longitudinal study · 2020
  Not checked
• The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease · 2020
  No notice
• Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis · 2020
  Corrected
• Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine · 2019
  No notice
• GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network · 2019
  No notice
• Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications · 2019
  No notice
• A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease · 2019
  No notice
• Association between the PPP1R3B polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke in a southern Chinese Han population · 2018
  Not checked
• Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis · 2018
  No notice
• Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers · 2018
  No notice
• Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver · 2017
  No notice

and 9 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.